chr3-123666344-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP6BS2
The NM_053025.4(MYLK):āc.3706A>Gā(p.Met1236Val) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,614,168 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_053025.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYLK | NM_053025.4 | c.3706A>G | p.Met1236Val | missense_variant, splice_region_variant | 22/34 | ENST00000360304.8 | NP_444253.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYLK | ENST00000360304.8 | c.3706A>G | p.Met1236Val | missense_variant, splice_region_variant | 22/34 | 5 | NM_053025.4 | ENSP00000353452 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000854 AC: 130AN: 152160Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000270 AC: 68AN: 251394Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135860
GnomAD4 exome AF: 0.000162 AC: 237AN: 1461890Hom.: 3 Cov.: 32 AF XY: 0.000153 AC XY: 111AN XY: 727244
GnomAD4 genome AF: 0.000900 AC: 137AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.000913 AC XY: 68AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 21, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Phosphorus, Inc. | Jan 14, 2022 | This missense variant represents an amino acid change of methionine with valine in codon 1236 of the MYLK gene; this codon is also within the splice region at the start of exon 22. This variant occurs in gnomAD with a total MAF of 0.0260% and highest MAF of 0.3790% in the African population, which is inconsistent with disease frequency. This position is not conserved. In silico functional models PolyPhen and SIFT predict this variant to be benign/tolerated; similarly, in silico splicing algorithms do not predict an impact to the splice site (MaxEntScan: 0.587). However, experimental functional or protein studies have not been performed to confirm these predictions. This variant is not present in the literature in association with disease. Considering this variant occurs relatively frequently and is not predicted to impact the protein or splicing, it is considered Likely Benign. - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jul 25, 2016 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 18, 2020 | - - |
Aortic aneurysm, familial thoracic 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at